Polyrizon (PLRZ) Stock Price, News & Analysis

Company Overview

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.

Key Stats

• Today's Range: $1.39 to $1.50
• 50-Day Range: N/A
• 52-Week Range: $0.77 to $4.80
• Volume: 74,876 shs
• Average Volume: 226,309 shs
• Market Capitalization: $6.08 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PLRZ Stock Analysis - Frequently Asked Questions

How have PLRZ shares performed this year?

Polyrizon's stock was trading at $2.17 at the beginning of 2025. Since then, PLRZ shares have decreased by 33.2% and is now trading at $1.45.
View the best growth stocks for 2025 here.

When did Polyrizon IPO?

Polyrizon (PLRZ) raised $4 million in an IPO on Tuesday, October 29th 2024. The company issued 958,903 shares at $4.38 per share.

When did Polyrizon's quiet period expire?

Polyrizon's quiet period expired on Monday, December 9th. Polyrizon had issued 958,903 shares in its IPO on October 29th. The total size of the offering was $4,199,995 based on an initial share price of $4.38. During Polyrizon's quiet period, insiders and any underwriters that worked on the IPO were prevented from issuing any earnings forecasts or research reports for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Polyrizon?

Shares of PLRZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Today: 1/14/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: N/A
• Current Symbol: NASDAQ:PLRZ
• CUSIP: N/A
• CIK: 1893645
• Web: www.polyrizon-biotech.com
• Phone: 972-55-433-5665
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 4,194,000
• Free Float: N/A
• Market Cap: $6.08 million
• Optionable: N/A
• Beta: N/A